Wnt Signaling Downregulation Mediates T Cell Apoptosis Following OKT3 ‐Induced T Cell Activation in Preclinical Models

Read full text Summarise with VIRAT
Authors: Myeongjin Choi, 박두현, Da‐Hee Lee, Chang Hoon Choi, Minseong Jo, Seo Yule Jeong, Seung Yeon Lim, Daeui Park, Kyoung‐Sik Moon
Cited by: 0
References: 50

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

ABSTRACT OKT3 is a murine monoclonal antibody (mAb) directed against human CD3 expressed on T cells and is known to induce T cell activation followed by activation‐induced cell death. This study investigated the role of canonical Wnt signaling in OKT3‐mediated T cell activation and apoptosis using preclinical models. In primary human PBMCs, OKT3 treatment downregulated the expression of canonical Wnt signaling‐related genes, whereas the Wnt pathway activator CHIR99021 upregulated their expression and reversed the OKT3‐induced suppression. OKT3 stimulation upregulated T cell activation markers (CD69, CD25), particularly in CD8 + T cells, and induced apoptosis as assessed by flow cytometry. Co‐treatment with CHIR99021 attenuated OKT3‐induced CD25 expression and late apoptosis, suggesting that Wnt signaling modulates T cell activation and cell death. In a humanized mouse model, OKT3 administration led to marked depletion of hCD3 + , hCD4 + , and hCD8 + T cells in the peripheral blood. Transcriptomic profiling using RNA‐seq of liver‐infiltrating human immune cells revealed significant upregulation of genes involved in T cell activation, apoptosis, cytokine signaling, and oxidative stress, accompanied by widespread downregulation of Wnt signaling genes (CTNNB1, LRP6, DVL1, FZD family). Therefore, these findings suggest that OKT3 induces T cell responses characterized by activation and subsequent apoptosis, in association with Wnt signaling. This study provides mechanistic insight into OKT3‐mediated immunomodulation and supports preclinical evaluation of T cell‐targeting monoclonal antibodies.

Fields of Study & Subjects

Wnt/β-catenin signaling in development and cancer T-cell and B-cell Immunology Signaling Pathways in Disease

Publication details

Journal / source
The FASEB Journal
Volume
40
Issue
6
Pages
e71700–e71700
Publication date
21 March 2026
Language
EN